Organon & Co | Pre Utilidad Fiscal



Pre Tax Profit Cambio Fecha
Bristol-Myers Squibb USD 4.26B 226M 2024-12
Celltrion KRW 273.99B 95.74B 2024-12
Cspc Pharmaceutical CNY 944.38M 798.51M 2024-09
Dianthus Therapeutics USD -28440000 3.27M 2024-12
Gilead Sciences USD 2.96B 112M 2024-12
Glaxosmithkline USD 1.66B 1.78B 2024-12
Kangmei Pharma -5720000 15.38M 2024-09
Knight Therapeutics CAD -7144000 19.01M 2024-03
Laboratorios Farma 121.55M 84.42M 2024-12
Medical Developments International AUD -6390000 0 2023-12
Merck USD 5.22B 114M 2024-12
Neuren Pharmaceuticals AUD 171.1M 159.25M 2024-12
Novartis USD 4.66B 269M 2024-12
Organigram Holdings CAD -22957000 4.15M 2024-12
Organon & Co 129M 78M 2024-12
Pharma Mar EUR 9.54M 5.66M 2024-12
Qiagen NV USD 169.1M 52.64M 2024-12
Sartorius EUR 99.5M 69.5M 2025-03
Tilray USD -83239000 49.47M 2024-11



Organon & Co Pre Utilidad Fiscal - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2025.